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Abstract
Background: Recent reports highlight the incursion of community-associated MRSA within healthcare settings. However,
knowledge of this phenomenon remains limited in Latin America. The aim of this study was to evaluate the molecular
epidemiology of MRSA in three tertiary-care hospitals in Medellı ´n, Colombia.
Methods: An observational cross-sectional study was conducted from 2008–2010. MRSA infections were classified as either
community-associated (CA-MRSA) or healthcare-associated (HA-MRSA), with HA-MRSA further classified as hospital-onset
(HAHO-MRSA) or community-onset (HACO-MRSA) according to standard epidemiological definitions established by the U.S.
Centers for Disease Control and Prevention (CDC). Genotypic analysis included SCCmec typing, spa typing, PFGE and MLST.
Results: Out of 538 total MRSA isolates, 68 (12.6%) were defined as CA-MRSA, 243 (45.2%) as HACO-MRSA and 227 (42.2%)
as HAHO-MRSA. The majority harbored SCCmec type IVc (306, 58.7%), followed by SCCmec type I (174, 33.4%). The
prevalence of type IVc among CA-, HACO- and HAHO-MRSA isolates was 92.4%, 65.1% and 43.6%, respectively. From 2008
to 2010, the prevalence of type IVc-bearing strains increased significantly, from 50.0% to 68.2% (p=0.004). Strains harboring
SCCmec IVc were mainly associated with spa types t1610, t008 and t024 (MLST clonal complex 8), while PFGE confirmed that
the t008 and t1610 strains were closely related to the USA300-0114 CA-MRSA clone. Notably, strains belonging to these
three spa types exhibited high levels of tetracycline resistance (45.9%).
Conclusion: CC8 MRSA strains harboring SCCmec type IVc are becoming predominant in Medellı ´n hospitals, displacing
previously reported CC5 HA-MRSA clones. Based on shared characteristics including SCCmec IVc, absence of the ACME
element and tetracycline resistance, the USA300-related isolates in this study are most likely related to USA300-LV, the
recently-described ‘Latin American variant’ of USA300.
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Introduction
Since its emergence in 1961, methicillin-resistant Staphylococcus
aureus (MRSA) has traditionally been considered a nosocomial
pathogen. In recent years, however, community-associated MRSA
(CA-MRSA) has emerged as an important global public health
problem [1]. Healthcare-associated MRSA (HA-MRSA) infections
generally occur in individuals with predisposing risk factors such as
surgery or presence of indwelling medical devices, whereas CA-
MRSA infections typically occur in otherwise healthy individuals
who do not exhibit such risk factors [2]. Eleven SCCmec types
(SCCmec I-XI) have been described to date [3,4]; of these, SCCmec
types I, II and III are characteristic of traditional HA-MRSA
strains, while types IV, V and VI are generally associated with CA-
MRSA [1].
In recent years, however, the distinction between HA-MRSA
and CA-MRSA has become increasingly blurred, with a growing
number of reports indicating that CA-MRSA strains are spreading
in hospital settings and replacing traditional HA-MRSA strains
[5,6,7,8,9,10,11,12,13,14,15].
In Colombia, MRSA constitutes an increasingly worrisome
clinical problem [5,12]; however, understanding of its molecular
epidemiology remains limited. Several HA-MRSA clones have
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currently classified as SCCmec type VI [16]), the Brazilian clone
(ST239-MRSA-III) and the Chilean clone (ST5-MRSA-I), mainly
in large tertiary hospitals in Bogota ´, the capital city [17,18]. In
addition, the CA-MRSA clone USA300 (ST8-MRSA-IV) has
recently been associated with nosocomial infections in Latin
America [5,12,19]. Most of the latter isolates belong to a distinct
Latin American variant of USA300 recently dubbed ‘‘USA300-
LV’’, which is characterized by carriage of SCCmec IVc, absence
of the arginine catabolic mobile element (ACME) and high
prevalence of tetracycline resistance [12,20]. Considering the
dynamic nature of MRSA epidemiology, it is imperative to
evaluate the situation in other regions of Colombia where MRSA
constitutes a severe problem. Accordingly, the aim of this study
was to evaluate the molecular epidemiology of MRSA strains
isolated from patients between 2008–2010 in three tertiary-care
hospitals in Medellı ´n, the second largest city in Colombia.
Methods
Study Population
An observational cross-sectional study was conducted at three
tertiary-care hospitals from February 2008 to June 2010.
Hospital A is a large 648-bed university hospital; Hospital B
is a 380-bed medium-size tertiary care center; and Hospital C is
a 140-bed cardiology hospital. All institutions are located in
Medellı ´n, the second largest city in Colombia. Sample sizes
were calculated based on the prevalence of MRSA at each
institution during 2007 (40.0% for Hospital A, 25.0% for
Hospital B and 10.0% for Hospital C). Patients infected with
MRSA were recruited prospectively and only the first isolate
from each individual was evaluated. A final sample of 538
MRSA isolates was included. The research protocol and
informed consent (signed by participants, parents, or guardians)
were approved by the Bioethics Committee for Human
Research of the University Research Center at Universidad de
Antioquia (CBEIH-SIU) (approval No 0841150), as well as by
the Ethics Committee in Research of Hospital Universitario San
Vicente Fundacio ´n, the Ethics Committee in Research of
Hospital Pablo Tobo ´n Uribe and the Ethics Committee in
Research of Clı ´nica Cardiovascular Congregacio ´n Mariana
(institutions where participants were recruited).
Clinical and Epidemiological Data
Clinical and epidemiological information was obtained from
medical records for each patient. Infections were classified as
either CA- or HA-MRSA, according to standard epidemiological
definitions established by the U.S. Centers for Disease Control and
Prevention (CDC) [21]. Healthcare-associated infections were
further classified as either community-onset (HACO) or hospital-
onset (HAHO) [21]. Infections were classified as HACO if (i)
positive MRSA culture was obtained within the first 48 hours of
hospital admission and (ii) at least one of the following healthcare-
associated risk factors was present: presence of an invasive device
at time of admission, history of MRSA infection, surgery,
hospitalization, dialysis, or intensive care unit (ICU) admission
during the 12 months preceding the culture date. Infections were
classified as HAHO if (i) positive MRSA culture was obtained 48
hours after hospital admission and (ii) at least one of the above-
mentioned risk factors was present. Lastly, infections were defined
as community-associated (CA) if positive MRSA culture was
obtained during the first 48 hours of hospital admission without
healthcare-associated risk factors.
Laboratory Methods
Susceptibility testing. Antibiotic susceptibilities of S. aureus
isolates were assessed in accordance with Clinical Laboratory
Standards Institute (CLSI) guidelines [22]. Antibiotics tested
included clindamycin, erythromycin, gentamicin, linezolid, moxi-
floxacin, oxacillin, rifampin, tetracycline, tigecycline, trimetho-
prim-sulfamethoxazole and vancomycin. S. aureus ATCC 29213
was used as a quality control strain.
PCR confirmation of S. aureus and methicillin
resistance. Presence of the species-specific nuc and femA genes,
as well as the mecA gene (determinant of methicillin resistance),
were verified by polymerase chain reaction (PCR) as previously
described [23,24].
SCCmec typing. SCCmec types and subtypes were deter-
mined using two previously described sets of multiplex PCR
reactions [25,26]. MRSA strains used as positive controls for
SCCmec types and SCCmec IV subtypes were kindly provided by
Dr. Teruyo Ito (Juntendo University, Japan) and included:
NCTC10442 (SCCmec I), N315 (SCCmec II), 85/2082 (SCCmec
III), JCSC4744 (SCCmec IVa), JCSC2172 (SCCmec IVb), 81/108
(SCCmec IVc), JCSC4469 (SCCmec IVd), JCSC4796 (SCCmec IVg)
and WIS (SCCmec V).
Spa typing and multilocus sequence typing (MLST). The
polymorphic X region of the protein A gene (spa) was amplified
and sequenced as previously described [27]. Corresponding spa
types were assigned using eGenomics software, as described
previously [27,28]. Ridom spa-types were subsequently assigned
using the spa typing website (http://www.spaserver.ridom.de/)
developed by Ridom GmbH and curated by SeqNet.org
(http://www.SeqNet.org/) [29]. MLST was performed on a
representative subset of 54 isolates (,10% of all samples) using
the methodology described by Enright et al. [30]. Allele
numbers and sequence types (ST)s were assigned using the
database maintained at http://saureus.mlst.net/, while clonal
complexes (CC)s were inferred using eBURST analysis [31].
Clonal complexes for all remaining strains were inferred by spa
repeat pattern analysis [28], or by referring to the Ridom
SpaServer website.
Pulsed-field gel electrophoresis (PFGE). PFGE following
SmaI digestion was performed according to a protocol described
elsewhere [32]. DNA fragment patterns were normalized using
S. aureus strain NCTC8325. Band assignments were manually
adjusted after automatic band detection and only bands ranging
from 36 kb to 600 kb were utilized for analysis. Cluster analysis
was performed using the Dice coefficient in BioNumerics software
version 6.0 (Applied Maths, Sint-Martens-Latem, Belgium).
Dendrograms were generated by the unweighted pair group
method using average linkages (UPGMA), with 1% tolerance and
0.5% optimization settings. Similarity cutoffs of 80% and 95%
were used to define types and subtypes, respectively [32].
Representatives of the most common MRSA clones described in
Colombia (Chilean, Pediatric and USA300) were used as reference
strains.
Detection of staphylococcal virulence factors. Genes
encoding staphylococcal enterotoxins (sea, seb, sec, sed, see), toxic
shock syndrome toxin 1 (tst) and exfoliative toxins A and B (eta, etb)
were detected by multiplex PCR as previously described [24]. The
lukS/F-PV genes encoding Panton-Valentine leukocidin (PVL), as
well as the arcA gene from the USA300-associated arginine
catabolic mobile element (ACME), were also assayed by PCR
[33,34].
Statistical analyses. Categorical variables were compared
using Chi-square or Fisher’s exact tests, with p values #0.05
considered statistically significant. Statistical analyses were carried
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Results
Clinical and Epidemiological Data
A total of 538 MRSA isolates were obtained from patients
admitted to all three hospitals, including 345 patients from
Hospital A, 156 patients from Hospital B and 37 patients from
Hospital C. Among the patients included in the study, 355 (66.0%)
were males, while the median age among all patients was 39 years
(range 0 to 92 years). Using CDC criteria, 243 (45.2%) isolates
were classified as HACO-MRSA, 227 (42.2%) as HAHO-MRSA
and 68 (12.6%) as CA-MRSA. Variations in the prevalence of the
above classifications were found in each institution evaluated
(Table 1). Hospitals A and C had the highest prevalence of
HAHO-MRSA (48.1% and 51.4% respectively), while Hospital B
had the highest prevalence of HACO-MRSA (59.6%).
Most of the MRSA isolates were obtained from patients
admitted to the surgery department (22.6%), followed by internal
medicine (19.9%), orthopedics (19.7%), pediatrics (14.1%), ICU
(9.3%) and other medical services (8.9%). Isolates were most
commonly obtained from skin and soft tissue infections (40.8%),
followed by surgical site infections (16.2%), osteomyelitis (12.4%),
pneumonia (10.4%), central venous catheter-related bacteremia
(7.9%), primary bacteremia (5.8%) and other infections (6.5%)
including arthritis, urinary tract infections, conjunctivitis, menin-
gitis, otitis, tracheitis, orbital cellulitis and infected pulmonary
sequestration.
Characterization of MRSA Strains
Of the 538 MRSA isolates analyzed by multiplex PCR [25], the
SCCmec types of 521 (96.8%) could be determined. Seven different
Table 1. Classification of MRSA infections according to CDC epidemiological criteria.
Hospital
a CA-MRSA
b No. (%) HA-MRSA
c
Total no. (%)
HACO-MRSA
d No. (%) HAHO-MRSA
e No. (%)
A 46 (13.3) 133 (38.6) 166 (48.1) 345 (100.0)
B 21 (13.5) 93 (59.6) 42 (26.9) 156 (100.0)
C 1 (2.7) 17 (45.9) 19 (51.4) 37 (100.0)
Total 68 (12.6) 243 (45.2) 227 (42.2) 538 (100.0)
aA: Largest hospital, B: Medium-sized hospital, C: Cardiologic hospital.
bCA-MRSA: community-associated methicillin-resistant Staphylococcus aureus.
cHA-MRSA: healthcare-associated methicillin-resistant Staphylococcus aureus.
dHACO-MRSA: healthcare-associated, community-onset MRSA.
eHAHO-MRSA: healthcare-associated, hospital-onset MRSA.
doi:10.1371/journal.pone.0038576.t001
Figure 1. SCCmec types of MRSA-isolates from each hospital, classified according to CDC epidemiological criteria. Abbreviations: CA-
MRSA: community-associated methicillin-resistant Staphylococcus aureus; HACO-MRSA: healthcare-associated, community-onset methicillin-resistant
Staphylococcus aureus; HAHO-MRSA: healthcare-associated, hospital-onset methicillin-resistant Staphylococcus aureus.
doi:10.1371/journal.pone.0038576.g001
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MLST- clonal complex spa type
a SCCmec type
a n( % )
b
CC 1 t922 IVc 2 (0.4)
CC5 t149
d, t7279
d, t1311
d, t045, t143, t458
d,t653, t5756, t7275, t7280
d I 166 (31.9)
t002 II 3 (0.6)
t045
d, t002 IV
c 5 (1.0)
t002 IVa 4 (0.8)
t002
d, t045 IVc 5 (1.0)
CC 8 t1610, t304 I 5 (1.0)
t008 II 1 (0.2)
t1610 IV
c 1 (0.2)
t1635
e, t008
f IVa 17 (3.3)
t1610
f, t008
f, t024
f, t051, t068, t203, t301
f, t304, t574
f, t622, t656, t770,
t2849, t2953, t3060, t4146, t5751, t6442, t6869, t7277, t7278, t8746
IVc 286 (54.9)
CC9 t209 V 1 (0.2)
CC15 t1885 IVc 1 (0.2)
t228 V 1 (0.2)
CC30 t021
g, t012 IVc 4 (0.8)
t021 IVg 1 (0.2)
CC45 t050 I 2 (0.4)
t5211 IVc 1 (0.2)
CC59 t216 IVc 1 (0.2)
t216
h V 3 (0.6)
CC72 t148
i, t324 V 5 (1.0)
CC88 t2649 IVa 1 (0.2)
t5916 IVb 1 (0.2)
CC97 t267 IVc 1 (0.2)
CC101 t056 IVc 1 (0.2)
CC152 t355 I 1 (0.2)
CC188 t189
j IVc 1 (0.2)
aThe most prevalent spa type and SCCmec type are shown in boldface.
bNumber and percentage of isolates with a specific clonal complex (CC) and SCCmec type combination.
cSCCmec IV subtype could not be determined.
d,e,f,g,h,i,jMLST was performed on representative strains bearing these spa types, with the following results:
dST5 (n=15),
eST923 (n=2),
fST8 (n=33),
gST30 (n=1)
hST59
(n=1)
iST72 (n=1)and
jST188 (n=1) (Table S1).
doi:10.1371/journal.pone.0038576.t002
Figure 2. Changing patterns in the prevalence of ST8-MRSA-IVc and ST5-MRSA-I isolates from 2008 to 2010. Other: MRSA isolates with
different sequence type (ST) and/or SCCmec type.
doi:10.1371/journal.pone.0038576.g002
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e38576SCCmec types and subtypes were detected, including types I, II,
IVa, IVb, IVc, IVg and V. Among the 17 remaining isolates, 11
were non-typeable for SCCmec type and 6 were non-typeable for
SCCmec IV subtype. The majority of the typeable MRSA isolates
harbored SCCmec type IVc (306, 58.7%) followed by SCCmec type
I (174, 33.4%).The remaining SCCmec types were present at very
low frequency, including types II (4, 0.8%), IVa (23, 4.4%), IVb (2,
0.4%), IVg (1, 0.2%) and V (10, 1.9%), while SCCmec type III was
not detected at all. Isolates classified as CA-MRSA and HACO-
MRSA most commonly harbored SCCmec type IVc (92.4% and
65.1%, respectively), while HAHO-MRSA strains mainly har-
bored SCCmec type I (48.2%) in addition to SCCmec type IVc
(43.6%). Notably, SCCmec type IVc was the most frequent subtype
found in HAHO-MRSA (72.5%) from Hospital B (Figure 1),
suggesting that strains harboring SCCmec IVc have become a
major source of HA- as well as CA-MRSA infections.
All of the MRSA isolates were represented by 53 different spa
types (Table 2), with the most common types being t1610
(eGenomics 814, YHGFMBQBBLO, 25.6%), t149 (eGenomics
442, TO2MEMDMGMGMK, 20.9%), t008 (eGenomics 1,
YHGFMBQBLO, 12.6%) and t024 (eGenomics 363, YGFMBQ-
BLO, 10.7%). Among the 53 spa types, a total of 12 MLST clonal
complexes were found, with CC8 and CC5 accounting for 60.8%
and 34.1% of the isolates, respectively. Isolates belonging to spa
types t1610, t008 and t024 corresponded to CC8 and mainly
harbored SCCmec type IVc (99.2%), whereas the t149 isolates
corresponded to CC5 and harbored SCCmec type I exclusively
(Table 2, Table S1). Over the three year course of the study, ST8
isolates harboring SCCmec type IVc (primarily spa types t1610,
t008 and t024) increased significantly in frequency, from 46.5% in
2008 to 64.3% in 2010 (p,0.05). By contrast, ST5 isolates
harboring SCCmec type I decreased in frequency, from 39.9% in
2008 to 19.0% in 2010 (p,0.05) (Figure 2).
Twenty isolates from each of the most predominant CC8 spa
types were further analyzed by PFGE (Figure 3). Isolates belonging
to spa type t1610 and t008 were closely related to the USA300-
0114 CA-MRSA clone (ST8-MRSA-IVa), with similarity coeffi-
cients ranging from 80–85%, whereas the t024 isolates did not
appear to be related to this strain (similarity coefficient 73%).
However, when PFGE was performed simultaneously on all three
spa types, they all appeared to be closely related to USA300-0114
(.80% similarity coefficient) (Figure 4). Moreover, they did not
cluster separately by spa type when analyzed together. As
expected, the spa type t149 (CC5) isolates were closely related
(similarity coefficients ranging from 85–97%) to the Cordobes/
Chilean clone (ST5-MRSA-I), whereas isolates related to the
previously reported Pediatric clone (ST5-MRSA-IV, now classi-
fied as SCCmec type VI) were not found (data not shown).
The isolates displayed distinct virulence gene patterns according
to clonal complex and SCCmec type, with CC8 isolates harboring
SCCmec types IVa, IVc and V more likely to possess genes coding
for virulence factors. The genes for PVL (lukS/F-PV) were present
in isolates harboring most SCCmec types (except types II and IVg)
and were most frequently observed in isolates harboring SCCmec
type IVc (90.6%). Exfoliative toxin gene A (eta) was only detected
in a single CC8 strain harboring SCCmec type V, while exfoliative
toxin gene B (etb) was not detected at all. Various staphylococcal
enterotoxin genes were also associated with different SCCmec
types, with seb and sed being the most common. The ACME-arcA
gene, frequently associated with USA300-0114 strains, was not
detected in any of the isolates tested.
Antibiotic resistance to clindamycin, erythromycin, gentamicin,
moxifloxacin and tetracycline differed significantly among MRSA
isolates carrying SCCmec type I vs. SCCmec type IVc (p,0.0001).
ST5-MRSA-I isolates were resistant to clindamycin (90.1%),
erythromycin (94.8%), gentamicin (88.7%), moxifloxacin (28.7%),
rifampin (12.1%), tetracycline (4.6%) and trimethoprim-sulfa-
methoxazole (2.0%), whereas ST8-MRSA-IVc displayed much
lower resistance to clindamycin (3.6%), erythromycin (4.9%),
gentamicin (1.0%), moxifloxacin (0.5%), rifampin (0.7%) and
trimethoprim-sulfamethoxazole (0.8%), but significantly higher
resistance to tetracycline (45.9%). Overall, ST5-MRSA-I exhibited
four principal antimicrobial resistance patterns, whereas ST8-
MRSA-IVc exhibited two patterns (Figure 5). Without exception,
all MRSA isolates were susceptible to vancomycin, linezolid and
tigecycline.
Discussion
Molecular epidemiology studies have highlighted the continuing
global evolution and spread of different MRSA clones [35]. The
factors contributing to dissemination of MRSA clones are only
partially understood, but are thought to include migration of
human populations, ineffective methods to control MRSA
transmission and inadequate treatment strategies, including the
inappropriate selection and use of antibiotics [36]. Since 2003,
many reports have documented the spread of SCCmec type IV-
harboring CA-MRSA strains in hospital settings, primarily in
Europe and the United States (U.S.), but also in South America
[5,6,7,8,9,10,12,13,14,15]. Partly as a result of this incursion, the
epidemiologic distinction between CA-MRSA and HA-MRSA has
become increasingly blurred. Understanding of this phenomenon
remains limited in Latin America, mostly due to a relative lack of
studies documenting the current epidemiology of MRSA in
institutions within these countries. Accordingly, this study focuses
on the epidemiology of MRSA in three important tertiary-care
hospitals in Medellı ´n, Colombia.
Our findings confirm a high prevalence of SCCmec type IVc-
bearing isolates (traditionally associated with CA-MRSA) in local
hospitals, where they are currently circulating as nosocomial
pathogens along with HA-MRSA strains harboring SCCmec type I.
In this study, SCCmec type IVc was predominant in isolates
classified as CA-MRSA (92.4%) and HACO-MRSA (65.1%),
while among HAHO-MRSA the frequency of SCCmec type IVc
(43.6%) was nearly as high as that of SCCmec type I (48.2%).
Moreover, differences in the prevalence of SCCmec type IVc were
found among the three hospitals in our study. For example, in
Hospital B, SCCmec IVc was found more frequently among
HAHO-MRSA isolates (72.5%), whereas in Hospital C, HA-
MRSA isolates (both HACO and HAHO) mainly harbored
SCCmec type I (47.1% and 54.7%, respectively). In our study, the
emergence of SCCmec type IVc in hospital settings was primarily
observed in CC8 strains exhibiting three spa types (t1610, t008,
t024). Data collected over the course of the study highlight the
expansion of these strains, which increased in prevalence from
2008 (46.5%) to 2010 (64.3%).
Figure 3. Genetic relatedness between CC8 MRSA isolates, stratified by spa type. UPGMA dendrogram showing genetic relatedness
between representative CC8 MRSA isolates in this study, as determined by PFGE with SmaI and stratified according to spa type: (A) spa type t1610
isolates, (B) spa type t008 isolates and (C) spa type t024 isolates. The broken line corresponds to the cutoff level (80%) used to define related PFGE
clones.
doi:10.1371/journal.pone.0038576.g003
CC8 MRSA with SCCmec IVc in Colombian Hospitals
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38576CC8 MRSA with SCCmec IVc in Colombian Hospitals
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38576SCCmec type IVc has been found in other widely disseminated
CA-MRSA clones, such as the Oceania-South West Pacific clone
(ST30-MRSA-IVc), which was initially described in New Zealand
[37] and subsequently isolated from nearly every continent [2]. In
South America, it has been reported in CC30 strains from Brazil,
Uruguay and, more recently, Argentina [6,13,38,39,40,41], while
several reports have described an SCCmec type IVc-bearing
variant of USA300 in Colombia, Ecuador, Venezuela, Peru,
Argentina and Trinidad and Tobago [5,20]. This Latin American
variant, recently dubbed ‘‘USA300-LV’’ [20], is distinguished
from prototypical USA300-0114 strains in that it harbors SCCmec
IVc rather than IVa, lacks the ACME element and is frequently
resistant to tetracycline. Although USA300-LV control strains [12]
were not available for comparative analysis, the SCCmec IVc-
harboring USA300-related strains in our study also possessed these
characteristics and are most likely representatives of the USA300-
LV lineage.
Currently, t008 (CC8) is the fourth most common spa type in the
Ridom database (5.93%) and is represented in most European
countries, Argentina, Canada and especially the U.S., where it
accounts for the majority of USA300 CA-MRSA isolates [1]. It is
also the primary spa type associated with USA300-LV, which has
been reported in several countries outside of Latin America,
including Spain, Italy, Belgium, the Netherlands, the United
Kingdom and Australia [20]. Spa type t024 (CC8), while less
common than t008 (0.78% in Ridom), is also widespread globally,
particularly in Denmark [1]. By contrast, in our study the most
common spa type (25.7%) among all 538 MRSA isolates was t1610
(CC8), which has been isolated in Spain, Germany, Sweden,
Norway, Canada and the U.S., but has a low overall frequency in
the Ridom database (0.01%). Lastly, t149 (CC5), associated
primarily with the SCCmec type I isolates in our study, is one of the
most common spa types in South America, including Argentina,
Brazil, Chile and Paraguay and is related to the previously
described Cordobes/Chilean clone [42,43].
Overall, the single most prevalent lineage in this study was ST8-
MRSA-IVc (55.0%), followed by ST5-MRSA-I (31.7%). By
contrast, an earlier report from Colombia [18] found that MRSA
strains isolated from 1996–1998 at five hospitals in Bogota ´
displayed 80% homology to the Pediatric clone (ST5-MRSA-IV,
currently classified as VI), which is characterized by a multi-
resistant phenotype. However, this lineage was completely absent
from the isolates analyzed in this study. In a subsequent study
conducted by Cruz et al. [17], the Cordobes/Chilean clone (ST5-
MRSA-I) was shown to be the dominant nosocomial strain from
2001–2003. More recently, an ST8-MRSA-IV clone related to
USA300 (i.e., USA300-LV) was described as causing CA-MRSA
infections in Colombia [44], with reports of nosocomial infections
surfacing in 2009 and 2010 [5,12]. In this study, the prevalence of
the ST8-MRSA-IVc clone appeared to increase over time, such
that presently it is the predominant clone causing both CA-MRSA
as well as HA-MRSA infections.
The most prevalent lineages observed in our study were notably
different from those found in other South American regions,
where ST5-MRSA-II, ST5-MRSA-IV, ST30-MRSA-IV and
ST239-MRSA-III appear to predominate [19]. In addition, the
Cordobes/Chilean ST5-MRSA-I clone, highly prevalent in South
American HA-MRSA infections, is being displaced by the ST8-
MRSA-IVc clone in Medellı ´n. These results highlight the
geographic diversity among MRSA strains and the predominantly
Figure 4. Genetic relatedness between CC8 MRSA isolates, without stratification. UPGMA dendrogram showing genetic relatedness
between representative CC8 MRSA isolates in this study as determined by PFGE with SmaI, without stratification by spa type. Note that t008, t024 and
t1610 isolates do not cluster separately by PFGE.
doi:10.1371/journal.pone.0038576.g004
Figure 5. Antibiotic resistance profiles of isolates from each hospital according to MRSA genotype. Abbreviations: CLI, clindamycin; ERY,
erythromycin; GEN, gentamicin; OXA, oxacillin; RIF, rifampin; TET, tetracycline; TMP, trimethroprim-sulfamethoxazole.
doi:10.1371/journal.pone.0038576.g005
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with successive clonal replacement observed over time. Moreover,
they emphasize the importance of local surveillance and dissem-
ination of findings, in order to ensure that medical personnel are
aware of changing patterns of MRSA epidemiology within their
institutions, thereby enabling them to choose efficacious empirical
treatments. In addition, these results, along with similar reports
from hospitals in various different countries [5,32,33,45,46],
suggest that the use of SCCmec type IV as a genetic marker for
CA-MRSA is of increasingly limited significance.
The differences observed in spa typing and virulence gene
content, in conjunction with the results of PFGE, suggest the
presence of considerable genetic diversity among the ST8-MRSA-
IVc strains that have become established in Medellı ´n. In this study,
we performed spa typing prior to PFGE, then compared different
spa-based PFGE clusters to USA300-0114, as well as to other
clones previously reported in Colombia. As shown in Figure 3,
whereas the t1610 and t008 isolates were closely related to
USA300-0114 (.80% similarity), the t024 isolates did not appear
to be related (similarity coefficient 73%). However, when analyzed
together (Figure 4), all three spa types were closely related to
USA300-0114 by PFGE (.80% similarity) and did not cluster
separately. These results are similar to those of a previous study
from Denmark [45], in which t008 and t024 isolates were
indistinguishable by PFGE. In this study, the t024 strains were
genetically distinct from USA300-0114 by PFGE, but possessed
the same characteristics as t1610 and t008, including SCCmec IVc,
absence of ACME and tetracycline resistance. It is therefore likely
that all three ST8-MRSA-IVc spa types belong to the USA300-LV
lineage. Nevertheless, in accordance with Larsen et al’s recom-
mendations [45], spa typing allowed for differentiation of clones
which could not be discriminated using PFGE alone. These
findings are relevant since studies performed in Colombia and
South America typically report the dissemination of USA300
based solely on PFGE [5,12], whereas our results also suggest that
additional methods such as spa typing should be performed to
differentiate genetically and epidemiologically distinct strains.
Taken together, the data from this study suggest that CC8
MRSA strains harboring SCCmec IVc are becoming predominant
in Medellı ´n hospitals. In addition to the previously described spa
type t008 USA300 strains [5,12], two novel ST8-MRSA-IVc spa
types (t024 and t1610) have been identified for the first time in
Latin America. Given the transmissibility and potential virulence
of CA-MRSA strains, continued increase in the prevalence,
severity and complexity of infections caused by these emerging
clones may lead to greater morbidity, mortality and hospitalization
costs [11,47]. Rigorous surveillance is therefore necessary in
Colombia and Latin America, in order to heighten awareness of
contemporary MRSA clones circulating in specific countries and
institutions and mitigate their impact on the design of effective
strategies for controlling MRSA transmission. Unfortunately,
individual hospitals within Colombia have typically implemented
their own infection control policies. Recently, however, the
National Institute of Health has started implementing a national
surveillance program for healthcare-related infections, including
antimicrobial consumption and resistance patterns, within hospi-
tals.
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